Medicare Enrolled

Dr. Sudama Reddi, M.D.

Neurology · Plano, TX
6124 W PARKER RD, Plano, TX 75093
9724033100
Registered in NPPES since 2011
NPI: 1184904583 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reddi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Reddi

Dr. Sudama Reddi is a neurology specialist in Plano, TX, with 15 years of NPI registration.

Between the years covered by Open Payments, Dr. Reddi received a total of $2,403 from 35 pharmaceutical and/or device companies across 141 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Reddi is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years of NPI registration $2,403 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,403
Total received (2018-2024)
Avg $343/year across 7 years
Top 50% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
141
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$17
2023
$41
2022
$41
2021
$197
2020
$28
2019
$204
2018
$1,875

Payments by company (2024)

ABBVIE INC.
$17
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Alexion Pharmaceuticals, Inc.
$230
AbbVie Inc.
$226
Supernus Pharmaceuticals, Inc.
$170
Amgen Inc.
$166
Adamas Pharmaceuticals, Inc.
$150
EMD Serono, Inc.
$124
Sunovion Pharmaceuticals Inc.
$110
ABBVIE INC.
$99
AbbVie, Inc.
$87
UCB, Inc.
$83
Bausch Health US, LLC
$83
US WorldMeds, LLC
$72
Novartis Pharmaceuticals Corporation
$64
GENZYME CORPORATION
$63
PFIZER INC.
$62
ACADIA Pharmaceuticals Inc
$60
Biogen, Inc.
$52
Acorda Therapeutics, Inc
$46
Bayer HealthCare Pharmaceuticals Inc.
$36
Upsher-Smith Laboratories LLC
$36
Assertio Therapeutics, Inc.
$36
Genentech USA, Inc.
$35
GE Healthcare
$32
ASSERTIO THERAPEUTICS, Inc.
$31
Egalet US Inc
$29
Medtronic USA, Inc.
$29
GE HEALTHCARE
$28
Teva Pharmaceuticals USA, Inc.
$28
Mallinckrodt Enterprises LLC
$27
Avanir Pharmaceuticals, Inc.
$25
Promius Pharma LLC
$22
Eisai Inc.
$21
Validus Pharmaceuticals LLC
$17
ARBOR PHARMACEUTICALS, INC.
$12
Piramal Imaging Limited
$11
Top 3 companies account for 26.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AMPYRA · APOKYN · APTIOM · AUBAGIO · Aimovig · Betaseron · COPAXONE · Cambia · DUOPA · Duopa · Equetro · Fycompa · GOCOVRI · Horizant · LEADPOINT · LEMTRADA · LO LOESTRIN FE · LYRICA · MIGRANAL · NEURACEQ · NUEDEXTA · NUPLAZID · Neupro · OCREVUS · OXTELLAR XR · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Rebif · SOLIRIS · SPRIX · TROKENDI XR · TYSABRI · UBRELVY · Vimpat · Xadago · Zembrace · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Plano?
Compare neurologists in the Plano area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
234
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Reddi is a neurology specialist, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Reddi receive payments from pharmaceutical companies?
Yes. Dr. Reddi received a total of $2,403 from 35 companies across 141 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Reddi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Plano
Browse neurologists in Plano ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →